Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
Thursday, May 29, 2008 - 12:28
in Health & Medicine
Virginia Commonwealth University Massey Cancer Center researchers have identified that a combination of novel anti-cancer compounds is able to kill chronic myelogenous leukemia cells previously resistant to conventional forms of therapy.